Hierarchical Cross-Modal Fusion for Drug-Target Binding Affinity Prediction
Related Experiment Video
Updated: Nov 7, 2026

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
Published on: June 20, 2025
Abstract:
Predicting drug-target affinity is a fundamental task in computational drug discovery. Existing methods often rely on a single view or perform shallow multimodal fusion, which may lead to view-specific bias and insufficient coordination among heterogeneous representations. As a result, they often fail to fully capture the complementary biochemical and structural cues underlying drug-target interactions. In this work, we propose TriM-DTA, a hierarchical cross-modal fusion framework for predicting drug-target binding affinity. TriM-DTA jointly models molecular sequence, 2D topology, and 3D geometry of both drugs and targets, and progressively integrates these heterogeneous views into a unified affinity-aware representation. By coordinating structural information before deeper cross-modal interaction, TriM-DTA reduces cross-view mismatch and enables more effective coupling of semantic, topological, and geometric cues. Experimental results demonstrate that TriM-DTA consistently outperforms existing methods and exhibits strong generalizability to unseen drugs and proteins. In addition, visualization analyses reveal that TriM-DTA captures binding-related patterns and highlights chemically meaningful substructures, providing interpretable evidence for its predictions. These findings suggest that coordinated multimodal representation learning provides a useful basis for broader molecular modeling tasks in drug discovery.
Related Concept Videos
Protein-Drug Binding: Determination Methods
Indirect methods involve isolating the bound drug from its free form in biological samples such as blood, serum, or plasma. These techniques aim to measure the percentage of drugs bound to proteins. Equilibrium dialysis is a commonly used method where the free drug concentration at equilibrium is measured by separating the bound...
Protein-Drug Binding: Mechanism and Kinetics
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
Drug Binding to Blood Components
HSA is the most abundant plasma protein and is vital in drug binding. It contains distinct drug-binding sites, with different drugs exhibiting affinity for specific sites. There are three main drug-binding domains for HSA: sites I, II, and III. These domains are further...
Ligand Binding Sites
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Ligand Binding and Linkage